Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Today St. Kitts & Nevis.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on June 24, 2025
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
June 24, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
Pediatric Dentist Dr. Molly Gunsaulis of Dentistry for Children Shares Expert Insight on Understanding Tongue-Ties and Their Impact in HelloNation
GlobeNewswire
·
June 24, 2025
SPOKANE VALLEY, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- What are the lasting effects of tongue-ties in children, and when should parents seek treatment? Dr. Molly Gunsaulis of Dentistry for Children in Spokane Valley, Washington addresses this in …
SciSparc Announces 1-for-21 Reverse Share Split
GlobeNewswire
·
June 24, 2025
Tel Aviv, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central …
Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
GlobeNewswire
·
June 24, 2025
BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
GlobeNewswire
·
June 24, 2025
GAITHERSBURG, Md., June 24, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
NeuroPace Announces Strategic CFO Transition
GlobeNewswire
·
June 24, 2025
Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory Role MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) …
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
GlobeNewswire
·
June 24, 2025
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia
GlobeNewswire
·
June 24, 2025
– PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML and R/R KMT2Ar acute leukemia – NEW YORK, June 24, …
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the closing of its initial seed …
Virginia Beach Boy Shot in Head Finds Road to Recovery at Children's Hospital of The King's Daughters
GlobeNewswire
·
June 24, 2025
Norfolk, Virginia, June 24, 2025 (GLOBE NEWSWIRE) -- NORFOLK, Va. – Emily Rigsby and Steven Davis sat next to their son, Landyn, in the pediatric intensive care unit desperately watching for any sign that he would be OK. The 8-year-old had been playing …
Shiny Smile Veneers Named Top Snap-On Veneer Brand in the US by Independent Review Platforms
GlobeNewswire
·
June 24, 2025
Houston, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Shiny Smile Veneers, a US-based provider of custom-made snap-on veneers, has once again been recognized as one of the top snap-on veneer brands in the country, this time by two leading dental product resources …
Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight
GlobeNewswire
·
June 24, 2025
New York, USA, June 24, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight Multiple Sclerosis, the most common neurological disorder in young adults, with …
Lulutox Tea UK (Lulutox Tea Detox) Officially Launches in Ireland, USA, Australia & Canada for Natural Digestive Cleanse
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- Lulutox™, a rising name in wellness and herbal nutrition, is excited to announce the official launch of its flagship product, Lulutox Detox Tea, across international markets including Ireland, the United …
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
GlobeNewswire
·
June 24, 2025
MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging biomedical device company focused on the …
First Steroid Cycle 2025: Experts Discuss Science Behind Beginner’s Guide to Choise Best Steroids for Muscle Growth, Bulking & Cutting By CrazyBulk
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- How First-Time Users Can Build Muscle with Confidence’ Ultimate Beginner’s Guide to Steroid Cycles: Safe, Legal, and Effective Alternatives for Muscle Growth and Performance in 2025 Launches By CrazyBulk. …
National Fitness Partners Raises Over $24,000 for Make-A-Wish Foundation
GlobeNewswire
·
June 24, 2025
CAMP HILL, Pa., June 24, 2025 (GLOBE NEWSWIRE) -- National Fitness Partners (NFP), a leading Planet Fitness franchisee, is proud to announce it has raised $24,121.61 in support of Make-A-Wish Foundation, helping grant life-changing wishes for children with …
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
GlobeNewswire
·
June 24, 2025
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
GlobeNewswire
·
June 24, 2025
DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …
Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …